FDA
approval
· 2013-07-01
FDA Approved: RIZATRIPTAN BENZOATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
Summary
The FDA approved Glenmark’s Rizatriptan Benzoate as a generic formulation for the acute treatment of migraine, representing the original generic approval for th…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)